The 2023 Research!America Annual Meeting of Members highlighted our 2022 accomplishments and featured special guest speakers. This gathering, for leadership, staff, employees, and students of member institutions and organizations, was held on April 20, 2023, 1:00–2:15 p.m. ET Agenda Highlights: Hear from Research!America’s newly elected Board Chair, Sudip Parikh, PhD Remarks from U.S. Representative Lauren […]
Rebecca Cunningham, MD, Vice President for Research at the University of Michigan, joined us to discuss the role of research in addressing firearm injury as the individual and societal toll of this deadly public health threat grows. Watch the recording and view her slides.
Please join us for a Research!America members-only alliance discussion featuring Meena Seshamani, Director of Center for Medicare at Centers for Medicare & Medicaid Services. Dr. Seshamani will discuss the CMS response to the Inflation Reduction Act.
John Crowley, Chairman and CEO, Amicus Therapeutics, joined us to discuss the personal journey that led to his remarkable impact on progress against rare diseases, and the path to dramatically faster progress going forward. Watch the recording.
We were joined by Dr. Ned Sharpless, who among his many distinctions served as the Director of the National Cancer Center under the Trump and Biden Administrations. Dr. Sharpless sat down with leading health policy expert and commentator Susan Dentzer, in a conversation focused on the National Institutes of Health. What does NIH do, how […]
Sara Maskornick, Democratic Staff Director of the Senate Health, Education, Labor and Pensions Subcommittee on Children & Families, joined us for a closed-door, alliance member-only meeting to provide an update on the Senate’s efforts to develop and secure passage of legislation to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA). Signed into law in 2006, […]
Gary Gibbons, MD, Director of the NIH National Heart, Lung, and Blood Institute, joined us for a Zoom conversation about where we stand in the fight against sickle cell disease (SCD). SCD affects over 20 million people worldwide, including nearly 100,000 in the U.S. alone. Progress against this disease has been tragically slow. However, recent […]
Steven Grossman, Executive Director of Alliance for a Stronger FDA, joined us to discuss all things FDA, including recent developments bearing on FDA’s role in the R&D ecosystem and the President’s FY 24 budget. Watch the recording.
May is Lupus Awareness Month, an opportune time to explore the “process behind progress” in the fight against this and other high-cost, high-burden diseases. Please join us on Monday, May 22, 2023, for an in-person lunch briefing with speakers representing the full spectrum of the health and medical research continuum, who will discuss their roles […]
Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research (CBER) at FDA, joined us for a members-only alliance discussion to discuss efforts to shape a robust, cost- and time-efficient regulatory review pathway for advances in gene therapy. Offering unimagined hope for the treatment and cure of rare childhood diseases and other […]
More than 27,000 individuals – many of them luminaries in the field of artificial intelligence (AI) -- have signed an open letter by the Future of Life Institute calling for a pause in the training of AI systems more powerful than GPT-4. Given the widespread implications of AI for research and health (and virtually everything else), key signatory, Vincent Conitzer, […]
Neil Vora, MD, a physician with Conservation International, joined us to discuss his work in addressing pandemic prevention. His work focuses on the link between human health and the health of the planet – particularly as it relates to the increasing threat of viruses that can ‘spillover’ from animals to humans – and how policy […]
